Humulin R Articles
Pfizer announces Exubera job cuts; Wyeth may cut workforce 10%
4 February 2008
Japan stock market week to Jan 28, 2008
4 February 2008
Oramed oral insulin product completes Ph Ia trial
21 January 2008
Japan stock market week toJan 14, 2008
21 January 2008
Resveratrol may help counter diabetes
21 January 2008
Novo Nordisk hires Alan Moses
14 January 2008
Tokyo stocks to January 7, 2008
14 January 2008
Lilly to invest in Italian insulin production
14 January 2008
More NCEs added to Japan's NHI reimbursement list late December
14 January 2008
Novo Nordisk licenses preclinical hemophilia candidate
24 December 2007
Chromium picolinate aids cognitive function
24 December 2007
Novo Nordisk settles law suit with Pfizer over Exubera
17 December 2007
Generex to import insulin spray into Abu Dhabi
17 December 2007
Novo Nordisk launches Changing Diabetes Barometer
17 December 2007
UPDATE: MedImmune's biologics capabilities to boost AstraZeneca's flagging pipeline
17 December 2007
Dia-B Tech's ISF402 achieves encouraging Ph I data
10 December 2007
Pfizer looks to increase outsourcing to 30%
10 December 2007
Raft of pending patent expiries threaten cardiovascular blockbusters
10 December 2007
Octreotide implant sees 6-month efficacy
10 December 2007
Merck KGaA confirms end of diabetes R&D
10 December 2007
UPDATE: Sanofi-Aventis to invest 100 million euros in new Chinese flu vaccine facility
3 December 2007
US hospital drug errors highlighted
3 December 2007
Stock Commentary - New York week to Nov 19
26 November 2007
Liraglutide cuts weight in obese non-diabetics
26 November 2007
Nordisk and Sciele sign marketing deal
26 November 2007
Lilly and JDRF partner on beta cell biomarker identification
19 November 2007
Novo Nordisk supports diabetes documentary
19 November 2007
Pfizer and Nektar resolve Exubera issues
19 November 2007
Akela sees positive Ph II results with its GHRA
19 November 2007
Headlines 25 years ago this week....
12 November 2007
Novo Nordisk's nine-month profit soars 60%
12 November 2007
Roche's R1507 effective at Ph I against solid tumors
5 November 2007
UPDATE: 2007 NASSO conference hears encouraging data on GSK's alli, Orexigen's Contrave et al
29 October 2007
GSK enters global TRX4 alliance with Tolerx
29 October 2007
Strong Ph IIb data on Orexigen's Contrave
29 October 2007
Generex signs S Africa Oral-lyn distribution deal
29 October 2007
Japan's MHLW clears Novo Nordisk's Levemir
29 October 2007
Eli lilly sees 3rd qtr net income climb 6% as sales jump 19% to $4.6B, raises full-year guidance
29 October 2007
Low dose red wine in mice fights diabetes
22 October 2007
EC clears S-P's Organon acquistion
22 October 2007
sNDA for Merck & Co's Januvia OKed
22 October 2007
Headlines 25 years ago this week....
22 October 2007
Boeh Ing and Vitae sign metabolics R&D deal
22 October 2007
Stock Commentary - New York week to Oct 8, 2007
15 October 2007
Tokyo stocks to October 8, 2007
15 October 2007
Nordisk's NovoRapid gains EC clearance
1 October 2007
Lack of HbA1c testing increasing risk to diabetes sufferers
1 October 2007
Eli Lilly's HumaPen Luxura available in the UK
24 September 2007
Large HbA1c reduction with Novo's liraglutide
24 September 2007
Japan stock market week to September 3, 2007
10 September 2007
Teijin and Chugai to develop Ipsen drug for Japan
10 September 2007
Medtronic and Bayer to sell glucose meter outside USA
3 September 2007
Liraglutide impresses in Ph III trials
3 September 2007
Millipore to distribute Novo's insulin for cell culture
3 September 2007
TMH sells SQ-PEN for insulin to DMI
20 August 2007
CombinatoRx initiates Ph IIa with CRx-401
20 August 2007
Oral-lyn comparable to injected insulin
20 August 2007
Oramed completes Ph Ia with oral insulin gel caps
20 August 2007
Ipsen/Tercica's Increlex approved in Europe
20 August 2007
Oramed closes $2 million financing
13 August 2007
Vectura's QDose shows efficacy in study
13 August 2007
Novo Nordisk's 2nd-qtr net profit soars 112%
13 August 2007
Promising preclinical data for Genaera's trodusquemine
6 August 2007
Dosing initiated in Ph III balaglitazone trial
6 August 2007
ReNeuron buys Amcyte assets for $4M
6 August 2007
Lilly's 2nd-qtr 20% sales hike beats estimates
30 July 2007
Merck & Co's 2nd-qtr 2007 EPS jumps 12%
30 July 2007
Japan stock market week to July 9, 2007
26 July 2007
ImClone starts Ph II enrollment for IMC-A12
23 July 2007
SMC OKs Lilly's Byetta as insulin alternative
23 July 2007
J&J's 2nd-qtr 2007 net income jumps 9.2%
23 July 2007
Tercica and Genentech sign R&D deal
16 July 2007
Generex announces Armenian Oral-lyn deal
16 July 2007
CV Thera identifies diabetes potential for Ranexa
16 July 2007
Japan stock market week to July 2, 2007
9 July 2007
WDF summit sponsor keeps a low profile
9 July 2007
Novo Nordisk to open $100M plant in NC, USA
2 July 2007
Liraglutide impresses in Ph II study
2 July 2007
Liraglutide gives better control than Lantus
2 July 2007
Japan stock market week to June 18, 2007
25 June 2007
Kissei and Eisai sign Glufast deal
25 June 2007
Norditropin gets FDA OK for Noonan syndrome
18 June 2007
Grapes protect against diabetes in rodents
28 May 2007
Tercica in manufacturing deal with Lonza
21 May 2007
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
